These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19207502)

  • 1. Familial hypercholesterolemia and cardiovascular disease a top concern for women.
    Gish BA
    Nurs Womens Health; 2009 Feb; 13(1):30-7. PubMed ID: 19207502
    [No Abstract]   [Full Text] [Related]  

  • 2. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
    van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pharmacologic treatments for familial hypercholesterolemia.
    McDonough A; Matura LA; Carroll D
    Nurs Womens Health; 2013 Oct; 17(5):443-7. PubMed ID: 24138664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of familial hypercholesterolemia and of the dyslipidemias responsible for cardiovascular disease].
    Sampietro T; Licitra R
    G Ital Cardiol; 1999 Feb; 29(2):171-3. PubMed ID: 10088075
    [No Abstract]   [Full Text] [Related]  

  • 5. Grand rounds from Rutgers Medical School. Familial hypercholesterolemia.
    Conn HL; Kuo PT; Khachadurian AK; Kostis JB
    Med Times; 1980 Apr; 108(4):112-6, 123-9. PubMed ID: 7360031
    [No Abstract]   [Full Text] [Related]  

  • 6. Women at risk of coronary heart disease experience barriers to diagnosis and treatment: a qualitative interview study.
    Frich JC; Malterud K; Fugelli P
    Scand J Prim Health Care; 2006 Mar; 24(1):38-43. PubMed ID: 16464813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional polymorphism in the glucocorticoid receptor gene and its relation to cardiovascular disease risk in familial hypercholesterolemia.
    Koeijvoets KC; van Rossum EF; Dallinga-Thie GM; Steyerberg EW; Defesche JC; Kastelein JJ; Lamberts SW; Sijbrands EJ
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4131-6. PubMed ID: 16849409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for familial hypercholesterolemia].
    Vandenbroucke JP
    Ned Tijdschr Geneeskd; 1996 Apr; 140(17):944-8. PubMed ID: 8676977
    [No Abstract]   [Full Text] [Related]  

  • 9. LRP1 gene polymorphisms are associated with premature risk of cardiovascular disease in patients with familial hypercholesterolemia.
    Aledo R; Alonso R; Mata P; Llorente-Cortés V; Padró T; Badimon L
    Rev Esp Cardiol (Engl Ed); 2012 Sep; 65(9):807-12. PubMed ID: 22819221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypercholesterolemia: current treatment and advances in management.
    Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study.
    Mundal L; Veierød MB; Halvorsen T; Holven KB; Ose L; Iversen PO; Tell GS; Leren TP; Retterstøl K
    Eur J Prev Cardiol; 2016 Dec; 23(18):1962-1969. PubMed ID: 27558979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is it necessary to institute primary preventive treatment in women with hypercholesterolemia?].
    Paquot N
    Rev Med Liege; 1999 Apr; 54(4):240-3. PubMed ID: 10389464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease in women with diabetes. Strategies for reducing its toll.
    Hart ND; McLeod MF; Fruh S
    Adv Nurse Pract; 1997 Aug; 5(8):32-6. PubMed ID: 9459952
    [No Abstract]   [Full Text] [Related]  

  • 14. [Coronary artery disease in heterozygous familial hypercholesterolemia (author's transl)].
    Hirobe K; Hara H; Kameda K; Tokunaga K; Kubo M; Sudo H; Matsuzawa Y; Ishikawa K; Tarui S; Yamamoto A; Nabu S; Fujimoto K
    Kokyu To Junkan; 1982 Jan; 30(1):87-93. PubMed ID: 7079619
    [No Abstract]   [Full Text] [Related]  

  • 15. The Unknown Risk of Familial Hypercholesterolemia in the Development of Atherosclerotic Cardiovascular Disease.
    Nascimento ED; Alves JLB
    Arq Bras Cardiol; 2021 Apr; 116(4):713-714. PubMed ID: 33886715
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperlipidemia and cardiovascular disease with focus on familial hypercholesterolemia.
    Holven KB; Ulven SM; Bogsrud MP
    Curr Opin Lipidol; 2017 Oct; 28(5):445-447. PubMed ID: 28857860
    [No Abstract]   [Full Text] [Related]  

  • 17. H3543Y mutation of apoB-100 in patients with phenotype of familial hypercholesterolemia.
    Basistová Z; Gasparovic J; Siváková D; Raslová K
    Atherosclerosis; 2007 Oct; 194(2):e185-7. PubMed ID: 17046772
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF
    Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
    [No Abstract]   [Full Text] [Related]  

  • 19. TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.
    Mohrschladt MF; van der Sman-de Beer F; Hofman MK; van der Krabben M; Westendorp RG; Smelt AH
    Eur J Hum Genet; 2005 Jul; 13(7):877-82. PubMed ID: 15856070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for familial hypercholesterolemia before the onset of cardiovascular complications.
    Sokal EM; Ulla L; Harvengt C; Otte JB
    Transplantation; 1993 Feb; 55(2):432-3. PubMed ID: 8434397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.